FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Rogers

Research Profile

Chemicals & Drugs

Living Beings

Candida albicans

Physiology

Devices

Oligonucleotide Array Sequence Analysis

Procedures

Co-author Network

Publications

TOP 3
Stephanie A Flowers; Scott E Gygax; Joachim Morschhäuser; Katherine S Barker; Elizabeth L Berkow; Sean G Chadwick; Geoffrey Toner; P David Rogers
Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans.
Ayala Ofir; P David Rogers; Esther Weindling; Katherine S Barker; Tsvia Gildor; Kay Hofmann; Daniel Kornitzer
Role of a Candida albicans Nrm1/Whi5 homologue in cell cycle gene expression and DNA replication stress response.
Sabrina Schubert; Christina Popp; P David Rogers; Joachim Morschhäuser
Functional dissection of a Candida albicans zinc cluster transcription factor, the multidrug resistance regulator Mrr1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Rogers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Stephanie A Flowers; Scott E Gygax; Joachim Morschhäuser; Katherine S Barker; Elizabeth L Berkow; Sean G Chadwick; Geoffrey Toner; P David Rogers
Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans.
Eukaryotic cell 2012;11(10):1289-99.
2012: Ayala Ofir; P David Rogers; Esther Weindling; Katherine S Barker; Tsvia Gildor; Kay Hofmann; Daniel Kornitzer
Role of a Candida albicans Nrm1/Whi5 homologue in cell cycle gene expression and DNA replication stress response.
Molecular microbiology 2012;84(4):778-94.
2011: Sabrina Schubert; Christina Popp; P David Rogers; Joachim Morschhäuser
Functional dissection of a Candida albicans zinc cluster transcription factor, the multidrug resistance regulator Mrr1.
Eukaryotic cell 2011;10(8):1110-21.
2011: Sabrina Schubert; Katherine S Barker; Sadri Znaidi; Sabrina Schneider; Franziska Dierolf; Nico Dunkel; Malika Aïd; Geneviève Boucher; P David Rogers; Martine Raymond; Joachim Morschhäuser
Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans.
Antimicrobial agents and chemotherapy 2011;55(5):2212-23.
2011: Selene Mogavero; Arianna Tavanti; Sonia Senesi; P David Rogers; Joachim Morschhäuser
Differential requirement of the transcription factor Mcm1 for activation of the Candida albicans multidrug efflux pump MDR1 by its regulators Mrr1 and Cap1.
Antimicrobial agents and chemotherapy 2011;55(5):2061-6.
2011: Christoph Sasse; Rebecca Schillig; Sabrina Schneider; Michael Weyler; Franziska Dierolf; Selene Mogavero; P David Rogers; Joachim Morschhäuser
The transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans.
PloS one 2011;6(9):e25623.
2010: Christopher F Hoehamer; Edwin D Cummings; George M Hilliard; P David Rogers
Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents.
Antimicrobial agents and chemotherapy 2010;54(5):1655-64.
2010: Clemens J. Heilmann; Sabrina Schneider; Katherine S Barker; P David Rogers; Joachim Morschhäuser
An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans.
Antimicrobial agents and chemotherapy 2010;54(1):353-9.
2009: Christopher F Hoehamer; Edwin D Cummings; George M Hilliard; Joachim Morschhäuser; P David Rogers
Proteomic analysis of Mrr1p- and Tac1p-associated differential protein expression in azole-resistant clinical isolates of Candida albicans.
Proteomics. Clinical applications 2009;3(8):968-78.
2008: Sabrina Schubert; P David Rogers; Joachim Morschhäuser
Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains.
Antimicrobial agents and chemotherapy 2008;52(12):4274-80.
2008: Nico Dunkel; Julia Blass; P David Rogers; Joachim Morschhäuser
Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains.
Molecular microbiology 2008;69(4):827-40.
2008: Nico Dunkel; Teresa T Liu; Katherine S Barker; Ramin Homayouni; Joachim Morschhäuser; P David Rogers
A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.
Eukaryotic cell 2008;7(7):1180-90.
2008: Jason M Cota; Jodi Grabinski; Robert L Talbert; David S Burgess; P David Rogers; Thomas D Edlind; Nathan Wiederhold
Increases in SLT2 expression and chitin content are associated with incomplete killing of Candida glabrata by caspofungin.
Antimicrobial agents and chemotherapy 2008;52(3):1144-6.
2007: Joachim Morschhäuser; Katherine S Barker; Teresa T Liu; Julia BlaB-Warmuth; Ramin Homayouni; P David Rogers
The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans.
PLoS pathogens 2007;3(11):e164.
2007: Teresa T Liu; Sadri Znaidi; Katherine S Barker; Lijing Xu; Ramin Homayouni; Saloua Saidane; Joachim Morschhäuser; André Nantel; Martine Raymond; P David Rogers
Genome-wide expression and location analyses of the Candida albicans Tac1p regulon.
Eukaryotic cell 2007;6(11):2122-38.
2007: P David Rogers; Teresa T Liu; Katherine S Barker; George M Hilliard; B Keith English; Justin Thornton; Edwin Swiatlo; Larry McDaniel
Gene expression profiling of the response of Streptococcus pneumoniae to penicillin.
The Journal of antimicrobial chemotherapy 2007;59(4):616-26.
2006: John-Paul Vermitsky; Kelly D Earhart; W Lamar Smith; Ramin Homayouni; Thomas D Edlind; P David Rogers
Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
Molecular microbiology 2006;61(3):704-22.
2006: P David Rogers; John-Paul Vermitsky; Thomas D Edlind; George M Hilliard
Proteomic analysis of experimentally induced azole resistance in Candida glabrata.
The Journal of antimicrobial chemotherapy 2006;58(2):434-8.
2005: Katherine S Barker; Teresa Liu; P David Rogers
Coculture of THP-1 human mononuclear cells with Candida albicans results in pronounced changes in host gene expression.
The Journal of infectious diseases 2005;192(5):901-12.
2005: Teresa T Liu; Richard E Lee; Katherine S Barker; Richard E Lee; Lai Wei; Ramin Homayouni; P David Rogers
Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans.
Antimicrobial agents and chemotherapy 2005;49(6):2226-36.
2005: Richard E Lee; Teresa T Liu; Katherine S Barker; Richard E Lee; P David Rogers
Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans.
The Journal of antimicrobial chemotherapy 2005;55(5):655-62.
2005: Massoumeh Z Hooshdaran; George M Hilliard; P David Rogers
Application of proteomic analysis to the study of azole antifungal resistance in Candida albicans.
Methods in molecular medicine 2005;118():57-70.
2005: Katherine S Barker; P David Rogers
Application of deoxyribonucleic acid microarray analysis to the study of azole antifungal resistance in Candida albicans.
Methods in molecular medicine 2005;118():45-56.
2004: Katherine S Barker; Sarah Crisp; Nathan Wiederhold; Russell Lewis; Bart Bareither; James Eckstein; Robert Barbuch; Martin Bard; P David Rogers
Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.
The Journal of antimicrobial chemotherapy 2004;54(2):376-85.
2004: Massoumeh Z Hooshdaran; Katherine S Barker; George M Hilliard; Harald Kusch; Joachim Morschhäuser; P David Rogers
Proteomic analysis of azole resistance in Candida albicans clinical isolates.
Antimicrobial agents and chemotherapy 2004;48(7):2733-5.
2004: Harald Kusch; K Biswas; S Schwanfelder; Susanne Engelmann; P David Rogers; Michael Hecker; Joachim Morschhäuser
A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains.
Molecular genetics and genomics : MGG 2004;271(5):554-65.
2003: Ameeta K Agarwal; P David Rogers; Scott R Baerson; Melissa R Jacob; Katherine S Barker; John D Cleary; Larry Walker; Dale G Nagle; Alice M Clark
Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae.
The Journal of biological chemistry 2003;278(37):34998-5015.
2003: John D Cleary; Michael Schwartz; P David Rogers; Jacqueline de Mestral; Stanley W Chapman
Effects of amphotericin B and caspofungin on histamine expression.
Pharmacotherapy 2003;23(8):966-73.
2003: John D Cleary; P David Rogers; Stanley W Chapman
Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulations.
Pharmacotherapy 2003;23(5):572-8.
2003: Katherine S Barker; Margaret M Pearson; P David Rogers
Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae.
The Journal of antimicrobial chemotherapy 2003;51(5):1131-40.
2003: P David Rogers; Justin Thornton; Katherine S Barker; D Olga McDaniel; Gordon S Sacks; Edwin Swiatlo; Larry McDaniel
Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae.
Infection and immunity 2003;71(4):2087-94.
2003: P David Rogers; Katherine S Barker
Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates.
Antimicrobial agents and chemotherapy 2003;47(4):1220-7.
2003: Margaret M Pearson; P David Rogers; John D Cleary; Stanley W Chapman
Voriconazole: a new triazole antifungal agent.
The Annals of pharmacotherapy 2003;37(3):420-32.
2003: P David Rogers; Katherine S Barker; Vanessa Herring; Melissa Jacob
Heat-induced superaggregation of amphotericin B attenuates its ability to induce cytokine and chemokine production in the human monocytic cell line THP-1.
The Journal of antimicrobial chemotherapy 2003;51(2):405-8.
2003: P David Rogers; Robert E Kramer; Janice K Crews; Russell Lewis
The activity of amphotericin B against Candida albicans is not directly associated with extracellular calcium concentration.
The Journal of antimicrobial chemotherapy 2003;51(2):305-12.
2002: P David Rogers; Margaret M Pearson; John D Cleary; Donna C Sullivan; Stanley W Chapman
Differential expression of genes encoding immunomodulatory proteins in response to amphotericin B in human mononuclear cells identified by cDNA microarray analysis.
The Journal of antimicrobial chemotherapy 2002;50(6):811-7.
2002: P David Rogers; Katherine S Barker
Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA microarray analysis.
Antimicrobial agents and chemotherapy 2002;46(11):3412-7.
2001: John D Cleary; P David Rogers; Stanley W Chapman
Differential transcription factor expression in human mononuclear cells in response to amphotericin B: identification with complementary DNA microarray technology.
Pharmacotherapy 2001;21(9):1046-54.
2001: Douglas Slain; P David Rogers; John D Cleary; Stanley W Chapman
Intravenous itraconazole.
The Annals of pharmacotherapy 2001;35(6):720-9.
2000: P David Rogers; Jonathan Stiles; Stanley W Chapman; John D Cleary
Amphotericin B induces expression of genes encoding chemokines and cell adhesion molecules in the human monocytic cell line THP-1.
The Journal of infectious diseases 2000;182(4):1280-3.
1999: P David Rogers; Robert E Kramer; Stanley W Chapman; John D Cleary
Amphotericin B-induced interleukin-1beta expression in human monocytic cells is calcium and calmodulin dependent.
The Journal of infectious diseases 1999;180(4):1259-66.
1998: P David Rogers; John K Jenkins; Stanley W Chapman; Kenneth Ndebele; B A Chapman; John D Cleary
Amphotericin B activation of human genes encoding for cytokines.
The Journal of infectious diseases 1998;178(6):1726-33.
1998: C T King; P David Rogers; John D Cleary; Stanley W Chapman
Antifungal therapy during pregnancy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(5):1151-60.
1998: Stanley W Chapman; P David Rogers; M G Rinaldi; Donna C Sullivan
Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole.
Antimicrobial agents and chemotherapy 1998;42(4):978-80.